Torrent Pharmaceuticals Ltd Quarterly Results

Gross Sales

3,246

3,128

2,909

2,762

2,831

Excise Duty

0

0

0

0

0

Net Sales

3,246

3,128

2,909

2,762

2,831

Other Operating Income

56

50

50

47

58

Other Income

-27

-37

-18

33

-16

Total Income

3,275

3,141

2,941

2,842

2,873

Total Expenditure

2,232

2,146

2,019

1,895

1,950

PBIDT

1,043

995

922

947

923

Interest

48

56

56

57

64

PBDT

995

939

866

890

859

Depreciation

204

201

201

199

198

Minority Interest Before NP

0

0

0

0

0

Tax

233

201

184

153

156

Deferred Tax

-33

-11

-17

35

52

Reported Profit After Tax

591

548

498

503

453

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

591

548

498

503

453

Extra-ordinary Items

-9.17

0

-17.36

0

0

Adjusted Profit After Extra-ordinary item

600.17

548

515.36

503

453

EPS (Unit Curr.)

17.54

16.19

14.71

14.88

13.37

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

520

0

Equity

169.23

169.23

169.23

169.23

169.23

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

32.13

31.8

31.69

34.28

32.6

PBDTM(%)

30.65

30.01

29.76

32.22

30.34

PATM(%)

18.2

17.51

17.11

18.21

16